MedPath

Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents

Phase 2
Completed
Conditions
Tourette Syndrome
Interventions
Drug: Placebo
Registration Number
NCT04007991
Lead Sponsor
Emalex Biosciences Inc.
Brief Summary

This study evaluates the effect of ecopipam tablets in children and adolescents in the treatment of Tourette's Syndrome (TS). Half of the participants will receive ecopipam tablets, while the other half will receive matching placebo tablets

Detailed Description

Multicenter, placebo-controlled, double-blind, randomized, parallel-group, Phase 2b study in pediatric subjects (aged greater than equal to 6 to less than 18 years of age) with TS. Following a 28-day Screening period and Baseline visit, eligible subjects will be randomized 1:1 to receive either ecopipam hydrochloride (HCl) or matching placebo for a 12 week treatment period. Doses will be titrated up and down from target dose of 2 mg/kg/day. Follow Up visit will be conducted after the last dose of study medication.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
153
Inclusion Criteria
  • ≥ 6 and < 18 years of age
  • ≥ 18 kg (~ 40 lbs.)
  • TS diagnosis and both motor and vocal tics that cause impairment with normal routines
  • Minimum score of 20 on the YGTSS-Total Tic Score
  • May not be taking any medications used to treat motor or vocal tics for at least 14 days prior to Baseline.
  • Effective contraception during the study and 30 days after last study dose for sexually active subjects
Exclusion Criteria
  • Certain mood or psychiatric disorders (i.e., dementia, bipolar disorder, schizophrenia, major depressive disorder)
  • Unstable medical illness or clinically significant lab abnormalities
  • Risk of suicide
  • Pregnant or lactating women
  • Moderate to severe renal insufficiency
  • Hepatic insufficiency
  • Positive urine drug screen
  • Unstable doses for drugs to treat anxiety, depression, Attention Deficit Hyperactivity Disorder
  • Certain medications that would lead to drug interactions
  • Recent behavioral therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboMatching Placebo tablets taken orally in the evening
Ecopipam HCI 2 mg/kg/dayEcopipamEcopipam HCl 12.5-, 50-, 75- and 100-mg tablets; 2 mg/kg/day target dose; oral administration daily in evenings
Primary Outcome Measures
NameTimeMethod
Change From Baseline in the Yale Global Tic Severity Scale-Total Tic Score (YGTSS-TTS) at Week 12Baseline, Week 12

The YGTSS was a semi-structured clinical interview designed to measure the tic severity. This scale consisted of a tic inventory, with 5 separate rating scales to rate the severity of symptoms, and an impairment ranking. Ratings were made along 5 different dimensions on a scale of 0=none to 5=severe for motor and vocal tics, each including number, frequency, intensity, complexity, and interference. The YGTSS TTS was the summation of the severity scores of motor and vocal tics. The total tic score (TTS) ranged from 0 (none) to 50 (severe) with higher score represent more severe symptoms. A negative change from baseline indicates improvement.

Secondary Outcome Measures
NameTimeMethod
Change From Baseline in Clinical Global Impression of Tourette Syndrome Severity (CGI-TS-S) at Week 12Baseline, Week 12

Clinical Global Impression (CGI) scale was used to assess overall severity on a 7-point Likert scale consisted of 2 reliable and valid 7-item Likert scales used to assess severity and change in clinical symptoms. The CGI severity scale ranges from 1 = Normal, not at all ill; 2 = Borderline ill; 3 = Mildly ill; 4 = Moderately ill; 5 = Markedly ill; 6 = Severely ill; 7 = Among the most extremely ill subject. 1 = "normal, not ill at all" to 7 = "extremely ill." A negative change indicates improvement in the condition.

Trial Locations

Locations (70)

Harmonex Neuroscience Research

🇺🇸

Dothan, Alabama, United States

Advanced Research Center Inc.

🇺🇸

Anaheim, California, United States

Clinical Research Center of NJ

🇺🇸

Voorhees, New Jersey, United States

Rare Disease Research, LLC

🇺🇸

Atlanta, Georgia, United States

Dept. Child Adolescent Psychiatry Uni. Freiburg

🇩🇪

Freiburg, Germany

Zentralinstitut fuer Seelische Gesundheit

🇩🇪

Mannheim, Germany

Pharmakologisches Studienzentrum Chemnitz GmbH

🇩🇪

Mittweida, Germany

Centrum Bada Klinicznych PI-House Sp. z o.o.

🇵🇱

Gdansk, Poland

UCLA

🇺🇸

Los Angeles, California, United States

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

Syrentis Clinical Research

🇺🇸

Santa Ana, California, United States

Center for Psychiatry and Behavioral Medicine Inc.

🇺🇸

Las Vegas, Nevada, United States

Quest Therapeutics of Avon Lake

🇺🇸

Avon Lake, Ohio, United States

APG Research LLC

🇺🇸

Orlando, Florida, United States

Houston Clinical Trials LLC

🇺🇸

Bellaire, Texas, United States

Hapworth Research Inc.

🇺🇸

New York, New York, United States

Movement Disorders Center

🇺🇸

Saint Louis, Missouri, United States

Meridian Clinical Research

🇺🇸

Savannah, Georgia, United States

Psychiatric Associates

🇺🇸

Overland Park, Kansas, United States

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

Mood Disorders Consulting Medicine PLLC

🇺🇸

New York, New York, United States

The University of Chicago Hospitals

🇺🇸

Chicago, Illinois, United States

University Hospitals Cleveland Medical Center

🇺🇸

Cleveland, Ohio, United States

Cincinnati Childrens Hospital Medical Center

🇺🇸

Cincinnati, Ohio, United States

New York Neurology Associates P.C

🇺🇸

New York, New York, United States

Helen DeVos Children's Hospital / Spectrum Health Medical Group

🇺🇸

Wyoming, Michigan, United States

Mount Sinai School of Medicine

🇺🇸

New York, New York, United States

North Star Medical Research LLC

🇺🇸

Middleburg Heights, Ohio, United States

Finger Lakes Clinical Research

🇺🇸

Rochester, New York, United States

Noetic Psychiatry

🇺🇸

Springville, Utah, United States

CHU Sainte-Justine

🇨🇦

Montreal, Quebec, Canada

Relaro Medical Trials

🇺🇸

Dallas, Texas, United States

North Texas Clinical Trials

🇺🇸

Fort Worth, Texas, United States

Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School

🇩🇪

Hannover, Niedersachsen, Germany

Center for Pediatric Excellence

🇨🇦

Ottawa, Ontario, Canada

Uniwersyteckie Centrum Kliniczne

🇵🇱

Gdansk, Poland

Gdanskie Centrum Zdrowia Sp z o.o.

🇵🇱

Gdańsk, Poland

Centrum Medyczne Plejady

🇵🇱

Krakow, Poland

NZOZ Wielospecjalistyczna Poradnia Lekarska Synapsis

🇵🇱

Katowice, Poland

Wojewdzki Specjalistyczny Szpital Dziecicy im. sw. Ludwika w Krakowie

🇵🇱

Krakow, Poland

Med-Polonia Sp. z o. o.

🇵🇱

Poznań, Poland

PCSD-Feighner Research

🇺🇸

San Diego, California, United States

Sarkis Clinical Trials

🇺🇸

Gainesville, Florida, United States

Access Clinical Trials, Inc.

🇺🇸

Nashville, Tennessee, United States

Road Runner Research Ltd.

🇺🇸

San Antonio, Texas, United States

MedBio Trials

🇺🇸

North Miami, Florida, United States

AMR - Baber Research Inc.

🇺🇸

Naperville, Illinois, United States

St. Charles Psychiatric Associates dba Midwest Research Group

🇺🇸

Saint Charles, Missouri, United States

Pediatric Neurology, PA

🇺🇸

Winter Park, Florida, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Neurobehavioral Medicine Group

🇺🇸

Bloomfield Hills, Michigan, United States

Suburban Research Associates

🇺🇸

Media, Pennsylvania, United States

CHU Poitiers

🇫🇷

Poitiers, France

Eastside Therapeutic Resource Inc dba Core Clinical Research

🇺🇸

Everett, Washington, United States

Hopital Robert Debre

🇫🇷

Paris, Ile De France, France

Research in Miami Inc.

🇺🇸

Hialeah, Florida, United States

Baylor College of Medicine

🇺🇸

Houston, Texas, United States

Northwest Florida Clinical Research Group, LLC

🇺🇸

Gulf Breeze, Florida, United States

University of South Florida

🇺🇸

Saint Petersburg, Florida, United States

The Kids Clinic Inc

🇨🇦

Ajax, Ontario, Canada

University of Miami

🇺🇸

Miami, Florida, United States

Alivation Research, LLC

🇺🇸

Lincoln, Nebraska, United States

The NeuroCognitive Institute

🇺🇸

Mount Arlington, New Jersey, United States

Psychiatric Clinic of Ludwig Maximilians Universitaet Muenchen

🇩🇪

Muenchen, Bayern, Germany

Yale School of Medicine

🇺🇸

New Haven, Connecticut, United States

Phoenix Children's Hospital

🇺🇸

Phoenix, Arizona, United States

Pediatric Epilepsy and Neurology Specialists

🇺🇸

Tampa, Florida, United States

Michigan Clinical Research Institute PC

🇺🇸

Ann Arbor, Michigan, United States

Coastal Pediatric Research

🇺🇸

Charleston, South Carolina, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath